Oramed Pharmaceuticals Inc. · NASDAQ:ORMP
Kidron Nadav received 718,262 Oramed Pharmaceuticals Inc. shares as an award (Form 4)
Traded Sep 24, 2026 · Filed Sep 25, 2026
On Sep 24, 2026, Kidron Nadav (Director, President and CEO) received 718,262 Oramed Pharmaceuticals Inc. shares as an award, leaving 4,140,505 shares. Filed Sep 25, 2026 (Form 4).
- Awarded
- 718,262 shares
- Holding after
- 4,140,505 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 24, 2026 | Common Stock | Award | 349,497 | 3,771,740 | Direct | |
| Sep 24, 2026 | Common Stock | Award | 368,765 | 4,140,505 | Direct |